EMEA (Europe, Middle East and Africa) Inflammatory Bowel Disease Market Report 2018

February 2018 | 102 pages | ID: EF7DC82C9A5EN
QYResearch

Abstracts

In this report, the EMEA Inflammatory Bowel Disease market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Inflammatory Bowel Disease for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Inflammatory Bowel Disease market competition by top manufacturers/players, with Inflammatory Bowel Disease sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Abbvie
• Merck
• Abbott Laboratories
• Biogen Idec
• Janssen Pharmaceuticals
• Merck & Company
• Mitsubishi Tanabe
• Salix Pharmaceuticals
• Genentech
• Shire
• UCB
• Akebia Therapeutics
• Amgen
• ChemoCentryx
• Novartis
• Boehringer Ingelheim
• Celltrion
• Novo Nordisk
• Ferring Pharmaceuticals
• Galapagos

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 5-ASA
• Antibiotics
• Immunomodulators
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Inflammatory Bowel Disease Market Report 2018

1 INFLAMMATORY BOWEL DISEASE OVERVIEW

1.1 Product Overview and Scope of Inflammatory Bowel Disease
1.2 Classification of Inflammatory Bowel Disease
  1.2.1 EMEA Inflammatory Bowel Disease Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Inflammatory Bowel Disease Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 5-ASA
  1.2.4 Antibiotics
  1.2.5 Immunomodulators
  1.2.6 Other
1.3 EMEA Inflammatory Bowel Disease Market by Application/End Users
  1.3.1 EMEA Inflammatory Bowel Disease Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 EMEA Inflammatory Bowel Disease Market by Region
  1.4.1 EMEA Inflammatory Bowel Disease Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Inflammatory Bowel Disease (2013-2025)
  1.5.1 EMEA Inflammatory Bowel Disease Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Inflammatory Bowel Disease Revenue and Growth Rate (2013-2025)

2 EMEA INFLAMMATORY BOWEL DISEASE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Inflammatory Bowel Disease Market Competition by Players/Manufacturers
  2.1.1 EMEA Inflammatory Bowel Disease Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Inflammatory Bowel Disease Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Inflammatory Bowel Disease Sale Price by Players (2013-2018)
2.2 EMEA Inflammatory Bowel Disease (Volume and Value) by Type/Product Category
  2.2.1 EMEA Inflammatory Bowel Disease Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Inflammatory Bowel Disease Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Inflammatory Bowel Disease Sale Price by Type (2013-2018)
2.3 EMEA Inflammatory Bowel Disease (Volume) by Application
2.4 EMEA Inflammatory Bowel Disease (Volume and Value) by Region
  2.4.1 EMEA Inflammatory Bowel Disease Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Inflammatory Bowel Disease Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Inflammatory Bowel Disease Sales Price by Region (2013-2018)

3 EUROPE INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Inflammatory Bowel Disease Sales and Value (2013-2018)
  3.1.1 Europe Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
3.2 Europe Inflammatory Bowel Disease Sales and Market Share by Type
3.3 Europe Inflammatory Bowel Disease Sales and Market Share by Application
3.4 Europe Inflammatory Bowel Disease Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Inflammatory Bowel Disease Sales Volume by Countries (2013-2018)
  3.4.2 Europe Inflammatory Bowel Disease Revenue by Countries (2013-2018)
  3.4.3 Germany Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  3.4.4 France Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  3.4.5 UK Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  3.4.6 Russia Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  3.4.7 Italy Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)

4 MIDDLE EAST INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Inflammatory Bowel Disease Sales and Value (2013-2018)
  4.1.1 Middle East Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
4.2 Middle East Inflammatory Bowel Disease Sales and Market Share by Type
4.3 Middle East Inflammatory Bowel Disease Sales and Market Share by Application
4.4 Middle East Inflammatory Bowel Disease Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Inflammatory Bowel Disease Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Inflammatory Bowel Disease Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  4.4.4 Israel Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  4.4.5 UAE Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  4.4.6 Iran Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)

5 AFRICA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Inflammatory Bowel Disease Sales and Value (2013-2018)
  5.1.1 Africa Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
5.2 Africa Inflammatory Bowel Disease Sales and Market Share by Type
5.3 Africa Inflammatory Bowel Disease Sales and Market Share by Application
5.4 Africa Inflammatory Bowel Disease Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Inflammatory Bowel Disease Sales Volume by Countries (2013-2018)
  5.4.2 Africa Inflammatory Bowel Disease Revenue by Countries (2013-2018)
  5.4.3 South Africa Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Inflammatory Bowel Disease Sales and Growth Rate (2013-2018)

6 EMEA INFLAMMATORY BOWEL DISEASE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Abbvie
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbvie Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen Idec
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Idec Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Janssen Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck & Company
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck & Company Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Mitsubishi Tanabe
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mitsubishi Tanabe Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Salix Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Salix Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Genentech
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Inflammatory Bowel Disease Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Genentech Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Shire
6.12 UCB
6.13 Akebia Therapeutics
6.14 Amgen
6.15 ChemoCentryx
6.16 Novartis
6.17 Boehringer Ingelheim
6.18 Celltrion
6.19 Novo Nordisk
6.20 Ferring Pharmaceuticals
6.21 Galapagos

7 INFLAMMATORY BOWEL DISEASE MANUFACTURING COST ANALYSIS

7.1 Inflammatory Bowel Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Inflammatory Bowel Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Inflammatory Bowel Disease Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INFLAMMATORY BOWEL DISEASE MARKET FORECAST (2018-2025)

11.1 EMEA Inflammatory Bowel Disease Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Inflammatory Bowel Disease Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Inflammatory Bowel Disease Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Inflammatory Bowel Disease Price and Trend Forecast (2018-2025)
11.2 EMEA Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Inflammatory Bowel Disease Sales Forecast by Type (2018-2025)
11.7 EMEA Inflammatory Bowel Disease Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Inflammatory Bowel Disease
Figure EMEA Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2025)
Figure EMEA Inflammatory Bowel Disease Sales Volume Market Share by Type (Product Category) in 2017
Figure 5-ASA Product Picture
Figure Antibiotics Product Picture
Figure Immunomodulators Product Picture
Figure Other Product Picture
Figure EMEA Inflammatory Bowel Disease Sales Volume (MT) by Application (2013-2025)
Figure EMEA Sales Market Share of Inflammatory Bowel Disease by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Inflammatory Bowel Disease Market Size (Million USD) by Region (2013-2025)
Figure Europe Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Inflammatory Bowel Disease Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Inflammatory Bowel Disease Revenue (Million USD) Status and Forecast by Countries
Figure Africa Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Inflammatory Bowel Disease Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2025)
Figure EMEA Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Inflammatory Bowel Disease Market Major Players Product Sales Volume (MT) (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales Volume (MT) of Major Players (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales Share by Players (2013-2018)
Figure 2017 Inflammatory Bowel Disease Sales Share by Players
Figure 2017 Inflammatory Bowel Disease Sales Share by Players
Figure EMEA Inflammatory Bowel Disease Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Inflammatory Bowel Disease Revenue (Million USD) by Players (2013-2018)
Table EMEA Inflammatory Bowel Disease Revenue Share by Players (2013-2018)
Table 2017 EMEA Inflammatory Bowel Disease Revenue Share by Players
Table 2017 EMEA Inflammatory Bowel Disease Revenue Share by Players
Table EMEA Inflammatory Bowel Disease Sale Price (USD/Kg) by Players (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales (MT) and Market Share by Type (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales Share by Type (2013-2018)
Figure Sales Market Share of Inflammatory Bowel Disease by Type (2013-2018)
Figure EMEA Inflammatory Bowel Disease Sales Market Share by Type (2013-2018)
Table EMEA Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Inflammatory Bowel Disease Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Type in 2017
Table EMEA Inflammatory Bowel Disease Sale Price (USD/Kg) by Type (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales (MT) and Market Share by Application (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales Share by Application (2013-2018)
Figure Sales Market Share of Inflammatory Bowel Disease by Application (2013-2018)
Figure EMEA Inflammatory Bowel Disease Sales Market Share by Application in 2017
Table EMEA Inflammatory Bowel Disease Sales (MT) and Market Share by Region (2013-2018)
Table EMEA Inflammatory Bowel Disease Sales Share by Region (2013-2018)
Figure Sales Market Share of Inflammatory Bowel Disease by Region (2013-2018)
Figure EMEA Inflammatory Bowel Disease Sales Market Share in 2017
Table EMEA Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Inflammatory Bowel Disease Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Region (2013-2018)
Figure EMEA Inflammatory Bowel Disease Revenue Market Share Regions in 2017
Table EMEA Inflammatory Bowel Disease Sales Price (USD/Kg) by Region (2013-2018)
Figure Europe Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Europe Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
Table Europe Inflammatory Bowel Disease Sales (MT) by Type (2013-2018)
Table Europe Inflammatory Bowel Disease Market Share by Type (2013-2018)
Figure Europe Inflammatory Bowel Disease Market Share by Type in 2017
Table Europe Inflammatory Bowel Disease Sales (MT) by Application (2013-2018)
Table Europe Inflammatory Bowel Disease Market Share by Application (2013-2018)
Figure Europe Inflammatory Bowel Disease Market Share by Application in 2017
Table Europe Inflammatory Bowel Disease Sales (MT) by Countries (2013-2018)
Table Europe Inflammatory Bowel Disease Sales Market Share by Countries (2013-2018)
Figure Europe Inflammatory Bowel Disease Sales Market Share by Countries (2013-2018)
Figure Europe Inflammatory Bowel Disease Sales Market Share by Countries in 2017
Table Europe Inflammatory Bowel Disease Revenue (Million USD) by Countries (2013-2018)
Table Europe Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Inflammatory Bowel Disease Revenue Market Share by Countries in 2017
Figure Germany Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure France Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure UK Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Russia Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Italy Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Benelux Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Middle East Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Middle East Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Inflammatory Bowel Disease Sales (MT) by Type (2013-2018)
Table Middle East Inflammatory Bowel Disease Market Share by Type (2013-2018)
Figure Middle East Inflammatory Bowel Disease Market Share by Type (2013-2018)
Table Middle East Inflammatory Bowel Disease Sales (MT) by Applications (2013-2018)
Table Middle East Inflammatory Bowel Disease Market Share by Applications (2013-2018)
Figure Middle East Inflammatory Bowel Disease Sales Market Share by Application in 2017
Table Middle East Inflammatory Bowel Disease Sales Volume (MT) by Countries (2013-2018)
Table Middle East Inflammatory Bowel Disease Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Inflammatory Bowel Disease Sales Volume Market Share by Countries in 2017
Table Middle East Inflammatory Bowel Disease Revenue (Million USD) by Countries (2013-2018)
Table Middle East Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East Inflammatory Bowel Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Israel Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure UAE Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Iran Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Africa Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Inflammatory Bowel Disease Sales (MT) by Type (2013-2018)
Table Africa Inflammatory Bowel Disease Sales Market Share by Type (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales Market Share by Type (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales Market Share by Type in 2017
Table Africa Inflammatory Bowel Disease Sales (MT) by Application (2013-2018)
Table Africa Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Table Africa Inflammatory Bowel Disease Sales Volume (MT) by Countries (2013-2018)
Table Africa Inflammatory Bowel Disease Sales Market Share by Countries (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales Market Share by Countries (2013-2018)
Figure Africa Inflammatory Bowel Disease Sales Market Share by Countries in 2017
Table Africa Inflammatory Bowel Disease Revenue (Million USD) by Countries (2013-2018)
Table Africa Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Africa Inflammatory Bowel Disease Revenue Market Share by Countries (2013-2018)
Figure Africa Inflammatory Bowel Disease Revenue Market Share by Countries in 2017
Figure South Africa Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Nigeria Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Egypt Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Algeria Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Table Pfizer Inflammatory Bowel Disease Basic Information List
Table Pfizer Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Abbvie Inflammatory Bowel Disease Basic Information List
Table Abbvie Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Merck Inflammatory Bowel Disease Basic Information List
Table Merck Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Merck Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Abbott Laboratories Inflammatory Bowel Disease Basic Information List
Table Abbott Laboratories Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Biogen Idec Inflammatory Bowel Disease Basic Information List
Table Biogen Idec Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Merck & Company Inflammatory Bowel Disease Basic Information List
Table Merck & Company Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Mitsubishi Tanabe Inflammatory Bowel Disease Basic Information List
Table Mitsubishi Tanabe Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Salix Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Salix Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Genentech Inflammatory Bowel Disease Basic Information List
Table Genentech Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales Market Share in EMEA (2013-2018)
Figure Genentech Inflammatory Bowel Disease Revenue Market Share in EMEA (2013-2018)
Table Shire Inflammatory Bowel Disease Basic Information List
Table UCB Inflammatory Bowel Disease Basic Information List
Table Akebia Therapeutics Inflammatory Bowel Disease Basic Information List
Table Amgen Inflammatory Bowel Disease Basic Information List
Table ChemoCentryx Inflammatory Bowel Disease Basic Information List
Table Novartis Inflammatory Bowel Disease Basic Information List
Table Boehringer Ingelheim Inflammatory Bowel Disease Basic Information List
Table Celltrion Inflammatory Bowel Disease Basic Information List
Table Novo Nordisk Inflammatory Bowel Disease Basic Information List
Table Ferring Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Galapagos Inflammatory Bowel Disease Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease
Figure Inflammatory Bowel Disease Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Major Manufacturers in 2017
Table Major Buyers of Inflammatory Bowel Disease
Table Distributors/Traders List
Figure EMEA Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure EMEA Inflammatory Bowel Disease Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Inflammatory Bowel Disease Price (USD/Kg) and Trend Forecast (2018-2025)
Table EMEA Inflammatory Bowel Disease Sales (MT) Forecast by Region (2018-2025)
Figure EMEA Inflammatory Bowel Disease Sales Market Share Forecast by Region (2018-2025)
Table EMEA Inflammatory Bowel Disease Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Inflammatory Bowel Disease Revenue Market Share Forecast by Region (2018-2025)
Table Europe Inflammatory Bowel Disease Sales (MT) Forecast by Countries (2018-2025)
Figure Europe Inflammatory Bowel Disease Sales Market Share Forecast by Countries (2018-2025)
Table Europe Inflammatory Bowel Disease Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Inflammatory Bowel Disease Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Inflammatory Bowel Disease Sales (MT) Forecast by Countries (2018-2025)
Figure Middle East Inflammatory Bowel Disease Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Inflammatory Bowel Disease Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Inflammatory Bowel Disease Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Inflammatory Bowel Disease Sales (MT) Forecast by Countries (2018-2025)
Figure Africa Inflammatory Bowel Disease Sales Market Share Forecast by Countries (2018-2025)
Table Africa Inflammatory Bowel Disease Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Inflammatory Bowel Disease Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Inflammatory Bowel Disease Sales (MT) Forecast by Type (2018-2025)
Figure EMEA Inflammatory Bowel Disease Sales Market Share Forecast by Type (2018-2025)
Table EMEA Inflammatory Bowel Disease Sales (MT) Forecast by Application (2018-2025)
Figure EMEA Inflammatory Bowel Disease Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources